Related Experiment Video
Updated: Feb 8, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
The Right Heart-Pulmonary Circulation Unit in Systemic Hypertension
Olga Vriz1, Yoshiki Motoji2, Francesco Ferrara3
1Adult Cardiology Consultant, Heart Centre Department, King Faisal Hospital and Research Center, P.O. Box 3354 Riyadh, Saudi Arabia.
Systemic hypertension can lead to right ventricular (RV) failure, even with normal left ventricular function. Understanding this complication is key to preventing pulmonary vascular disease and improving RV health in hypertensive patients.
Area of Science:
- Cardiology
- Hypertension Research
- Right Ventricular Function
Background:
- Systemic hypertension is a known risk factor for left heart failure, particularly with preserved ejection fraction.
- Left heart failure can precipitate pulmonary hypertension, ultimately leading to right ventricular (RV) failure.
- Altered RV function has been observed in patients with mild to moderate hypertension, even when left ventricular systolic and diastolic functions are preserved.
Purpose of the Study:
- To investigate the unclear pathophysiology of right ventricular dysfunction in the context of systemic hypertension.
- To highlight the potential role of preserving RV function and preventing pulmonary vascular disease as therapeutic targets in managing systemic hypertension.
Main Methods:
- The abstract does not specify the methods used in the study.
Main Results:
- The abstract indicates that altered RV function occurs in hypertension, even with preserved left ventricular function.
- The pathophysiology linking systemic hypertension to RV dysfunction remains unclear.
Conclusions:
- Preserving RV function and preventing pulmonary vascular disease should be considered in the optimized therapy for systemic hypertension.
- Further research is needed to elucidate the mechanisms behind RV complications in hypertension.
More Related Videos
Related Concept Videos
Overview of Systemic and Pulmonary Circulation
The oxygenated blood is sent...
Overview of Pulmonary Circulation
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

